Pharmaceutical care issues encountered by post‐menopausal osteoporotic women prescribed bisphosphonates
WHAT IS KNOWN AND OBJECTIVE: Pharmacists have been involved in providing comprehensive interventions to osteoporosis patients, but pharmaceutical care issues (PCIs) encountered during such interventions have not been well documented. Therefore, the aim of this study was to document PCIs encountered...
Main Authors: | Lai, Pauline Siew Mei, Chua, Siew Siang, Chan, S.P. |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/9080/1/Lai-2012-Pharmaceutical_care.pdf |
Similar Items
-
Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic women
by: Lai, Pauline Siew Mei, et al.
Published: (2011) -
Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.
by: Watson, J, et al.
Published: (2007) -
Estrogenic post-menopausal anti-osteoporotic mechanism of Achyranthes aspera L.: Phytochemicals and network pharmacology approaches
by: Huq, AKM Moyeenul, et al.
Published: (2024) -
Estrogenic post-menopausal anti-osteoporotic mechanism of Achyranthes aspera L.: Phytochemicals and network pharmacology approaches
by: Moyeenul Huq, A. K. M., et al.
Published: (2024) -
Sexual dysfunction among post menopausal women
by: Wan Masliza WD,, et al.
Published: (2012)